Organization · Venture Capital
Pollen Group
Pollen Group is an Israel-based investment group established in 2020, focusing on nurturing entrepreneurs and impactful innovations through venture capital investments in sustainable technology, healthcare, and biotechnology.
Overview
What Pollen Group does
What Pollen Group is
Pollen Group is an Israel-based investment group established in 2020, focusing on nurturing entrepreneurs and impactful innovations through venture capital investments in sustainable technology, healthcare, and biotechnology.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2020
- Approximate age
- About 6 years
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find Pollen Group elsewhere
Open the official website or a supported primary organization account.
Capability profile
Pollen Group as a funder
Investment thesis
Pollen Group invests in companies that drive both financial returns and positive social and environmental impact, focusing on disruptive technologies that contribute to environmental and human well-being.
Focus narrative
Pollen Group specializes in impact investments across various sectors, including sustainable technology, healthcare innovation, and biotechnology. The organization supports early-stage and growth companies, adopting a hands-on partnership approach that includes mentorship, networking, and operational expertise. Pollen Group employs a patient capital strategy, committing to long-term support for its portfolio companies.
Value beyond capital
Pollen Group adds value to its portfolio companies through long-term support, mentorship, networking opportunities, and operational expertise, fostering a collaborative environment for growth and innovation.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+ · Growth Equity
- Regions
- Global
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 3
Portfolio context
KIP Medical: A biotechnology company that develops oral care products using the Spilanthes plant, combining traditional wisdom with advanced science for holistic oral wellness. ODE Pharma: A biotechnology firm focused on innovative treatments for respiratory and pulmonary disorders, leveraging the body's natural systems, including the gut microbiome and mitochondria. Kenaf Ventures: An Israeli CleanTech and ClimateTech company dedicated to carbon removal and reducing polluting feedstock in the industrial sector, creating renewable and biodegradable alternatives for insulation products.
Common questions
What to know about Pollen Group
Upseed classifies Pollen Group under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.